Table: Sapporo Clinical Lab -2017/18 group results

Sapporo Clinical Laboratory

11/05/2018 07:30

May 11 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           17.46           17.06          17.97         8.85    
               (+2.4 pct)      (-2.7 pct)     (+2.9 pct)    (+1.5 pct) 
  Operating        1.02          771 mln          1.04       473 mln   
               (+31.8 pct)     (-20.8 pct)    (+2.4 pct)    (-7.1 pct) 
  Recurring        1.05          803 mln          1.06       482 mln   
               (+31.0 pct)     (-19.6 pct)    (+0.5 pct)    (-7.6 pct) 
  Net
  Net            685 mln         513 mln        716 mln      326 mln   
               (+33.4 pct)     (-13.0 pct)    (+4.6 pct)    (-5.9 pct) 
  EPS          197.03 yen      147.69 yen     207.05 yen    94.22 yen  
  Ann Div       11.00 yen       10.00 yen      10.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       11.00 yen       10.00 yen      10.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T